nach oben

Erschienen in:

2021 | OriginalPaper | Buchkapitel

7. Enzephalitis

verfasst von : Uta Meyding-Lamadé, Eva Maria Craemer, Martin Stangel, Thorsten Lenhard, Burc Bassa, Christian Jacobi, Thomas Weber, Gabriele Arendt, Philipp Schwenkenbecher, Thomas Skripuletz, Inga Zerr, Stefan Schmiedel

Erschienen in: Neuroinfektiologie

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Virale Infektionen des Nervensystems sind häufig ein neurologischer Notfall und differenzialdiagnostisch anspruchsvoll und können durch eine Vielzahl von Erregern ausgelöst werden. Die rasche Diagnose und anschließende Therapie sind entscheidend für die Prognose des Patienten. Bakterielle Entzündungen des Nervensystems sind oft akut und lebensbedrohlich und erfordern unmittelbare Diagnose und Behandlung. Pilzinfektionen des zentralen Nervensystem (ZNS-Mykosen) finden sich oft bei Menschen mit angeborener oder erworbener Immunschwäche (z. B. HIV-Infektion, Diabetes mellitus oder Niereninsuffizienz) oder unter Behandlung mit immunsuppressiven Therapeutika (z. B. Chemotherapie oder nach Organtransplantation). Prionerkrankungen kommen beim Menschen als sporadische, erworbene und genetische Formen vor. Parasitäre Infektionserkrankungen des zentralen Nervensystems (ZNS) sind mannigfaltig und sowohl vom Erregerspektrum als auch von den unterschiedlichen Symptomen hochkomplex. Parasitäre Erkrankungen können sowohl als Meningitis, als Meningoenzephalitis, als reine Enzephalitis oder als Myelitis auftreten. In diesem Kapitel werden übersichtlich die wichtigsten bakteriellen, viralen, parasitären, Prion- und Pilzinfektionen beschrieben.

Alperovitch A et al (1999) Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 353:1673–1674PubMedCrossRef

Antinori A, Arendt G, Becker JT et al (2007) Updated research nosology for HIV-associated neurocognitive disorders (HAND). Neurology 69(18):1789–1799PubMedCrossRef

Atarashi R et al (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17:175–178PubMedCrossRef

Baldeiras IE et al (2009) Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients. J Neurol 256:1540–1550PubMedCrossRef

Beck JA et al (2010) PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit. Hum Mutat 31:E1551–E1563PubMedCrossRef

Bell JE, Ironside JW (1993) Neuropathology of spongiform encephalopathies in humans. Br Med Bull 49:738–777PubMedCrossRef

Bell JE et al (1997) Prion protein immunocytochemistry–UK five centre consensus report. Neuropathol Appl Neurobiol 23:26–35PubMedCrossRef

Brown P et al (1986) Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 20:597–602PubMedCrossRef

Brown DR et al (1997a) The cellular prion protein binds copper in vivo. Nature 390:684–687PubMedCrossRef

Brown DR et al (1997b) Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol 146:104–112PubMedCrossRef

Brown P et al (2012) Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis 18:901–907PubMedPubMedCentralCrossRef

Budka H (2000) Histopathology and immunohistochemistry of human transmissible spongiform encephalopathies (TSEs). Arch Virol Suppl 16:135–142. https://doi.org/10.1007/978-3-7091-6308-5_12. PMID: 11214916

Budka H et al (1995) Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5:459–466PubMedCrossRef

Bundesgesundheitsblatt (2012) Anforderungen an die Hygiene bei der Aufbereitung von Medizinprodukten. Springer, Heidelberg, S 1244–1310

Collie DA et al (2003) Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol 24:1560–1569PubMedPubMedCentral

Collinge J et al (1994) Prion protein is necessary for normal synaptic function. Nature 370:295–297PubMedCrossRef

Cramm M et al (2016) Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease. Mol Neurobiol 53:1896–1904PubMedCrossRef

Creutzfeldt HG (1920) Über deine eigenartige herdförmige Erkrankung des Zentralnervensystems. Z Ges Neurol Psychiat 57:1–18CrossRef

Duffy P et al (1974) Letter: possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 290:692–693PubMedCrossRef

Fenollar F, Puéchal X, Raoult D (2007) Whipple’s disease. New Engl J Med 356:55–66PubMedCrossRef

Green A et al (2007) CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies. Eur J Neurol 14:121–124PubMedCrossRef

Haik S et al (2014) Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 13:150–158PubMedCrossRef

Hamaguchi T et al (2005) Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. Neurology 64:643–648PubMedCrossRef

Heye N, Cervos-Navarro J (1992) Focal involvement and lateralization in Creutzfeldt-Jakob disease: correlation of clinical, electroencephalographic and neuropathological findings. Eur Neurol 32:289–292PubMedCrossRef

Hsich G et al (1996) The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 335:924–930PubMedCrossRef

INSIGHT START Study Group (2015) Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 373(9):795–807CrossRef

Jakob AM (1921) Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischem Befunden (Spastische Pseudosklerose- Encephalomyelopathie mit disseminierten Degenerationsherden). Dtsch Z Nervenheilk 70:132–146

Joint United Nations Programme on HIV/AIDS (2014) 90-90-90: an ambitious treatment target to help end the AIDS epidemic. UNAIDS, Geneva

Kallenberg K et al (2006) Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences. AJNR Am J Neuroradiol 27:1459–1462PubMedPubMedCentral

Khosravani H et al (2008) Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol 181:551–565PubMedPubMedCentralCrossRef

Koch TK et al (1985) Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. N Engl J Med 313:731–733PubMedCrossRef

Kovacs GG et al (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118:166–174PubMedCrossRef

Krasnianski A et al (2006a) Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol 63:876–880PubMedCrossRef

Krasnianski A et al (2006b) Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD. Brain 129:2288–2296PubMedCrossRef

Krasnianski A et al (2008) MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter-observer agreement study. Eur J Neurol 15:762–771PubMedCrossRef

Krasnianski A et al (2014) First symptom and initial diagnosis in sporadic CJD patients in Germany. J Neurol 261:1811–1817PubMedCrossRef

Krasnianski A et al (2017) Neuropsychological symptoms in sporadic Creutzfeldt-Jakob disease patients in Germany. J Alzheimers Dis 59:329–337PubMedCrossRef

Ladogana A et al (2005) High incidence of genetic human transmissible spongiform encephalopathies in Italy. Neurology 64:1592–1597PubMedCrossRef

Levy SR et al (1986) Early evolution and incidence of electroencephalographic abnormalities in Creutzfeldt-Jakob disease. J Clin Neurophysiol 3:1–21PubMedCrossRef

Luft BJ, Chua A (2000) Central nervous system toxoplasmosis in HIV pathogenesis, diagnosis, and therapy. Curr Infect Dis Rep 2:358–362. https://doi.org/10.1007/s11908-000-0016-x

Masters CL et al (1979) Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 5:177–188PubMedCrossRef

McGuire LI et al (2016) Cerebrospinal fluid real-time quaking-induced conversion is a robust and reliable test for sporadic creutzfeldt-jakob disease: an international study. Ann Neurol 80:160–165PubMedPubMedCentralCrossRef

Mead S et al (2006) Inherited prion disease with six octapeptide repeat insertional mutation–molecular analysis of phenotypic heterogeneity. Brain 129:2297–2317PubMedCrossRef

Meissner B et al (2004) Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings. Neurology 63:450–456PubMedCrossRef

Meissner B et al (2005) Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type. Neurology 65:1544–1550PubMedCrossRef

Meissner B et al (2008) Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 29:1519–1524PubMedCrossRefPubMedCentral

Meissner B et al (2009) MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology 72:1994–2001PubMedCrossRef

Muayqil T, Gronseth G, Camicioli R (2012) Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology 79:1499–1506PubMedPubMedCentralCrossRef

Neufeld MY, Korczyn AD (1992) Topographic distribution of the periodic discharges in Creutzfeldt-Jakob disease (CJD). Brain Topogr 4:201–206PubMedCrossRef

Oesch B et al (1985) A cellular gene encodes scrapie PrP 27–30 protein. Cell 40:735–746PubMedCrossRef

Otto A et al (1998) Akinetic mutism as a classification criterion for the diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 64:524–528PubMedPubMedCentralCrossRef

Otto M et al (2004) Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study. Neurology 62:714–718PubMedCrossRef

Palmer MS et al (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352:340–342PubMedCrossRef

Parchi P et al (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39:767–778PubMedCrossRef

Parchi P et al (1999) Molecular and clinicopathologic phenotypic variability in genetic Creutzfeldt-Jakob disease. Neurology 52:A323-324

Peden AH et al (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364:527–529PubMedCrossRef

Poser S, Zerr I (2002) Clinical aspects, diagnosis and therapeutic possibilities of human prion diseases. Internist (Berl) 43:731–737CrossRef

Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136–144PubMedCrossRef

Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363–13383PubMedCrossRefPubMedCentral

Prusiner SB et al (1984) Purification and structural studies of a major scrapie prion protein. Cell 38:127–134PubMedCrossRef

Sanchez-Juan P et al (2006) CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 67:637–643PubMedCrossRef

Sparkes RS et al (1986) Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc Natl Acad Sci USA 83:7358–7362PubMedCrossRefPubMedCentral

Spielmeyer W (1922) Die histopathologische Forschung in der Psychiatrie. Klinische Wochenschr 2:175–177

Steinhoff BJ et al (1996) Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 53:162–166PubMedCrossRef

Steinhoff BJ et al (1998) Elecroencephalographic charactistics of Creutzfeldt-Jakob disease and its differential diagnosis. Fortschr Neurol Psychiatr 66:357–365PubMedCrossRef

Steinhoff BJ et al (2004) Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol 56:702–708PubMedCrossRef

Stoeck K et al (2012) Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain 135:3051–3061PubMedPubMedCentralCrossRef

Tschampa HJ et al (2007) Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 28:1114–1118PubMedCrossRefPubMedCentral

Van Everbroeck B et al (2003) A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 74:1210–1214PubMedPubMedCentralCrossRef

Varges D et al (2017) Doxycycline in early CJD: a double-blinded randomised phase II and observational study. J Neurol Neurosurg Psychiatry 88:119–125PubMedCrossRef

Vitali P et al (2011) Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology 76:1711–1719PubMedPubMedCentralCrossRef

WHO (1998) Human transmissible spongiform encephalopathies. Wkly Epidemiol Rec 73:361–365

Wroe SJ et al (2006) Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 368:2061–2067PubMedCrossRef

Young GS et al (2005) Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 26:1551–1562PubMedPubMedCentral

Zeidler M et al (2000) The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 355:1412–1418PubMedCrossRef

Zerr I, Poser S (2002) Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests. APMIS 110:88–98PubMedCrossRef

Zerr I et al (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 43:32–40PubMedCrossRef

Zerr I et al (2000a) Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 55:811–815PubMedCrossRef

Zerr I et al (2000b) Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol 48:323–329PubMedCrossRef

Zerr I et al (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132:2659–2668PubMedPubMedCentralCrossRef

Zigas V, Gajdusek DC (1957) Kuru: clinical study of a new syndrome resembling paralysis agitans in natives of the Eastern Highlands of Australian New Guinea. Med J Aust 44:745–754PubMedCrossRef

Angelovich TA, Churchill MJ, Wright EJ, Brew BJ (2020) New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2019_126. Epub ahead of print. PMID: 32040843

anonymous (2019) Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. In: AIDS info. U.S. Department of Health and Human Services

Appolinario CM, Jackson AC (2015) Antiviral therapy for human rabies. Antivir Ther (Lond) 20:1–10CrossRef

Banyard AC et al (2019) Re-evaluating the effect of Favipiravir treatment on rabies virus infection. Vaccine 37:4686–4693PubMedCrossRef

Brand H-C, Gerloff C, Dietrich M (2017) Therapie und Verlauf neurologischer Erkrankungen, 7., erweiterte und überarbeitet Aufl. W. Kohlhammer. Stuttgart, ISBN-10:9783170316126

Carpio A, Romo ML, Parkhouse RM, Short B, Dua T (2016) Parasitic diseases of the central nervous system: lessons for clinicians and policy makers. Expert Rev Neurother 16(4):401–414. https://doi.org/10.1586/14737175.2016.1155454

Cieplik N, Stangel M, Bachmann O (2013) Neurologische Komplikationen entzündlicher Darmerkrankungen. Nervenarzt 84:190–196PubMedCrossRef

Cizman M, Jazbec J (1993) Etiology of acute encephalitis in childhood in Slovenia. Pediatr Infect Dis J 12:903–908PubMedCrossRef

Coelho C, Bocca AL, Casadevall A (2014) The intracellular life of Cryptococcus neoformans. Annu Rev Pathol 9:219–238PubMedCrossRef

Compain C, Sacre K, Puéchal X, Klein I, Vital-Durand D, Houeto JL, De Broucker T, Raoult D, Papo T (2013) Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up. Medicine 92:324–330PubMedPubMedCentralCrossRef

Cook GC, Zumla A (2008) Manson’s tropical diseases. Elsevier Health Sci. ISBN 070204332X, 9780702043321

Dacheux L et al (2008) A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis 47:1410–1417PubMedCrossRef

Dalla Costa G, Martinelli V, Moiola L, Sangalli F, Colombo B, Finardi A, Cinque P, Kolb EM, Haghikia A, Gold R, Furlan R, Comi G (2019) Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients. Ann Neurol 85:606–610PubMedCrossRef

Darai G, Handermann M, Sonntag H-G, Zöller L (2012) Lexikon der Infektionskrankheiten des Menschen: Erreger, Symptome, Diagnose, Therapie und Prophylaxe. Springer, Berlin. https://doi.org/10.1007/978-3-642-17158-1_1CrossRef

Deigendesch N, Schluter D, Siebert E et al (2019) Infections of the central nervous system by protozoa, helminths and fungi. Der Nervenarzt 90:623–641PubMedCrossRef

Eggimann P, Garbino J, Pittet D (2003) Management of Candida species infections in critically ill patients. Lancet Infect Dis 3:772–785PubMedCrossRef

El-Abassi R, Soliman MY, Williams F, England JD (2017) Whipple’s disease. J Neurol Sci 377:197–206PubMedCrossRef

Fowler Å, Stödberg T, Eriksson M, Wickström R (2008) Childhood encephalitis in Sweden: etiology, clinical presentation and outcome. Eur J Paediatr Neurol 12:484–490PubMedCrossRef

Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H (2019) Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry 90:870–881PubMedCrossRef

Goralska K, Blaszkowska J, Dzikowiec M (2018) Neuroinfections caused by fungi. Infection 46:443–459PubMedPubMedCentralCrossRef

Gottfredsson M, Perfect JR (2000) Fungal meningitis. Semin Neurol 20:307–322PubMedCrossRef

Hirsch HH, Kardas P, Kranz D, Leboeuf C (2013) The human JC polyomavirus (JCPyV): virological background and clinical implications. APMIS 121:685–727PubMedCrossRef

Jacobs CS, Etherton MR, Lyons JL (2014) Fungal infections of the central nervous system. Curr Infect Dis Rep 16:449PubMedCrossRef

Kaiser R et al (2020) Frühsommer-Meningoenzephalitis (FSME), S1-Leitlinie. In: Deutsche Gesellschaft für Neurologie (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie

Khetsuriani N, Holman RC, Anderson LJ (2002) Burden of encephalitis-associated hospitalizations in the United States, 1988–1997. Clin Infect Dis 35:175–182PubMedCrossRef

Khoury MN, Alsop DC, Agnihotri SP, Pfannl R, Wuthrich C, Ho ML, Hackney D, Ngo L, Anderson MP, Koralnik IJ (2014) Hyperintense cortical signal on magnetic resonance imaging reflects focal leukocortical encephalitis and seizure risk in progressive multifocal leukoencephalopathy. Ann Neurol 75(5):659–669

Kidd SE, Hagen F, Tscharke RL et al (2004) A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 101:17258–17263PubMedCrossRefPubMedCentral

Kneen R, Michael BD, Menson E, Mehta B, Easton A, Hemingway C et al (2012) Management of suspected viral encephalitis in children — Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group National Guidelines. J Infect 64:449e477

Konsiliarlaboratorium für Frühsommer-Meningoenzephalitis (FSME), Robert-Koch-Institut, Nordufer 20, 13.353 Berlin. www.rki.de

Koralnik IJ (2019) Can immune checkpoint inhibitors keep JC virus in check? N Engl J Med 380:1667–1668PubMedCrossRefPubMedCentral

Langenbruch L, Kramer J, Guler S, Moddel G, Gessner S, Melzer N, Elger CE, Wiendl H, Budde T, Meuth SG, Kovac S (2019) Seizures and epilepsy in multiple sclerosis: epidemiology and prognosis in a large tertiary referral center. J Neurol 266:1789–1795PubMedCrossRef

Lenhard T, Ott D, Jakob NJ, Pham M, Bäumer P, Martinez-Torres F et al (2016) Predictors, neuroimaging characteristics and long-term outcome of severe european tick-borne encephalitis: a prospective cohort study. PLoS One 11(4):e0154143. https://doi.org/10.1371/journal.pone.0154143survstat@rki.deCrossRefPubMedPubMedCentral

Lugassy MM, Louis ED (2006) Neurologic manifestations of Whipple’s disease. Curr Infect Dis Rep 8:301–306PubMedCrossRef

Melliez H, Mary-Krause M, Bocket L, Guiguet M, Abgrall S, De Truchis P, Katlama C, Martin-Blondel G, Henn A, Revest M, Robineau O, Khuong-Josses MA, Canestri A, De Castro N, Joly V, Mokhtari S, Risso K, Gasnault J, Costagliola D, French Hospital Database on HIV (2018) Risk of progressive multifocal leukoencephalopathy in the combination antiretroviral therapy era in the French hospital database on human immunodeficiency virus (ANRS-C4). Clin Infect Dis 67:275–282PubMedCrossRef

Meyding-Lamadé U, Craemer E, Jacobi C, Krone B, Pflausler B, Prange H, Schuchardt V (2018) Virale Meningoenzephalitis, S1-Leitlinie. In: Deutsche Gesellschaft für Neurologie (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie

Meyding-Lamadé U, Jacobi C, Martinez-Torres F, Lenhard T, Kress B, Kieser M, Klose C, Einhäupl K, Bösel J, Mackert M-B, Homberg V, Koennecke C, Weißheit G, Claus D, Kieseier B, Bardutzky J, Neumann-Haefelin T, Lorenz MW, Steinmetz H, Gerloff C, Schneider D, Grau A, Klein M, Dziewas R, Bogdahn U, Jakob W, Linker R, Fuchs K, Sander A, Luntz S, Hoppe-Tichy T, Hanley DF, von Kummer R, Craemer E (2019) The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter,randomized, double-blind, placebocontrolled trial. Neurol Res Pract. https://doi.org/10.1186/s42466-019-0031-3

Murthy JM, Sundaram C (2014) Fungal infections of the central nervous system. Handb Clin Neurol 121:1383–1401PubMedCrossRef

Nationales Referenzlabor für durch Zecken übertragene Krankheiten (NRL-ZüK), Friedrich- Loeffler-Institut, Bundesforschungsinstitut für Tiergesundheit, Standort Jena, Naumburger Str. 96a, 07.743 Jena. www.fli.de

Prado JCM, Monezi TA, Amorim AT, Lino V, Paladino A, Boccardo E (2018) Human polyomaviruses and cancer: an overview. Clinics (Sao Paulo) 73:e558s–e558sPubMedCentralCrossRef

Prange H (1995) Infektionskrankheiten des ZNS. Chapman & Hall, London. ISBN 3-8261-0066-2

Raschilas F, Wolff M, Delatour F, Chaffaut C, De Broucker T, Chevret S et al (2002) Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis 35:254–260CrossRefPubMed

Reiche W, Schuchardt V, Hagen T et al (2010) Differential diagnosis of intracranial ring enhancing cystic mass lesions – role of diffusion-weighted imaging (DWI) and diffusion- tensor imaging (DTI). Clin Neurol Neurosurg 112:218–225PubMedCrossRef

Reuwer AQ, Heron M, van der Dussen D, Schneider-Hohendorf T, Murk JL (2017) The clinical utility of JC virus antibody index measurements in the context of progressive multifocal leukoencephalopathy. Acta Neurol Scand 136(Suppl 201):37–44PubMedCrossRef

RKI – RKI-Ratgeber – Tollwut. https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Tollwut.html#doc2392880bodyText15

Robert Koch-Institut Abfrage der Meldedaten nach Infektionsschutzgesetz (IfSG) über das Web

Robert Koch-Institut (2018) Bericht zur Epidemiologie der Tuberkulose in Deutschland

Ross RS et al (2015) Instructive even after a decade: complete results of initial virological diagnostics and re-evaluation of molecular data in the German rabies virus ‚outbreak‘ caused by transplantations. Int J Med Microbiol 305:636–643PubMedCrossRef

Ruhnke M, Rickerts V, Cornely OA et al (2011) Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich- Society for Chemotherapy. Mycoses 54:279–310PubMedCrossRef

Rupprecht CE, Hanlon CA, Hemachudha T (2002) Rabies re-examined. Lancet Infect Dis 2:327–343PubMedCrossRef

Schaberg T et al (2017) S2k-Leitlinie: Tuberkulose im Erwachsenenalter. Pneumologie 71:325–397. https://doi.org/10.1055/s-0043-105954 (Georg Thieme Verlag KG, Stuttgart. ISSN 0934-8387)

Schmutzhard E, Pfausler B (2018) Tollwut und Bornavirus-Enzephalitis: Fatale „emerging“ virale Enzephalitis – ein potenzielles Problem bei Organempfängern. Der Nervenarzt 89:1332–1337PubMedCrossRef

Schwartz S, Kontoyiannis DP, Harrison T et al (2018) Advances in the diagnosis and treatment of fungal infections of the CNS. Lancet Neurol 17:362–372PubMedCrossRef

Siangphoe U et al (2020) Associations of antiretroviral therapy and comorbidities with neurocognitive outcomes in HIV-1 infected patients. AIDS. https://doi.org/10.1097/QAD.00000000000002491 [Epub ahead of print]

Skripuletz T, Schwenkenbecher P, Pars K et al (2014) Importance of follow-up cerebrospinal fluid analysis in cryptococcal meningoencephalitis. Dis Markers 2014:162576PubMedPubMedCentralCrossRef

Snydman DR, Walker M, Zunt JR (2005) Parasitic central nervous system infections in immunocompromised hosts. Clin Infect Dis 40(7):1005–1015

Solomon T, Michael BD, Smith PE, Sanderson F, Davies NWS, Hart IJ et al (2012) Management of suspected viral encephalitis in adults – Association of British Neurologists and British Infection Association National Guidelines. J Infect 64:347–373CrossRefPubMed

Sonneville R, Magalhaes E, Meyfroidt G (2017) Central nervous system infections in immunocompromised patients. Curr Opin Crit Care 23:128–133PubMedCrossRef

Thakur KT, Motta M, Asemota AO, Kirsch HL, Benavides DR, Schneider EB et al (2013) Predictors of outcome in acute encephalitis. Neurology 81:793–800PubMedPubMedCentralCrossRef

Tintelnot K, De Hoog GS, Haase G (2013) Fungal infections of the central nervous system in the immunocompetent host. Der Pathologe 34:534–539PubMedCrossRef

Tropeninstitut – Impfung – Tollwutimpfung. https://tropeninstitut.de/impfungen-a-z/alle-impfungen/tollwut?banner_unsubribe=true

Vukusic S, Rollot F, Casey R, et al (2020) Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France. JAMA Neurol 77(1):94–102. https://doi.org/10.1001/jamaneurol.2019.2670

Warrell MJ, Warrell DA (2004) Rabies and other lyssavirus diseases. Lancet 363:959–969PubMedCrossRef

Weber J et al Neurosyphilis, S1-Leitlinie. In: Deutsche Gesellschaft für Neurologie (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie

Weber T (2008) Progressive multifocal leukoencephalopathy. Neurol Clin 26:833–854PubMedCrossRef

Weber T, Trebst C, Frye S, Cinque P, Vago L, Sindic CJ, Schulz Schaeffer WJ, Kretzschmar HA, Enzensberger W, Hunsmann G, Luke W (1997) Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J-Infect-Dis 176:250–254PubMedCrossRef

WHO|Epidemiology and burden of disease. WHO. https://www.who.int/rabies/epidemiology/en/

WHO|Rabies vaccines: WHO position paper – April 2018. WHO. https://www.who.int/rabies/resources/who_wer9316/en/

WHO annual rabies cases – Google-Suche. https://www.google.com/search?client=safari&rls=en&q=WHO+annual+rabies+cases&ie=UTF-8&oe=UTF-8

Wijburg MT, Witte BI, Vennegoor A, Roosendaal SD, Sanchez E, Liu Y, Martins Jarnalo CO, Uitdehaag BM, Barkhof F, Killestein J, Wattjes MP (2016) MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance. J Neurol Neurosurg Psychiatry 87(10):1138–45. https://doi.org/10.1136/jnnp-2016-313772. Epub 2016 Aug 16. PMID: 27530808

Williamson PR, Jarvis JN, Panackal AA et al (2017) Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat Rev Neurol 13:13–24PubMedCrossRef

Zu Rhein GMu, Chou SM (1965) Particles resembling papovavirions in human cerebral demyelinating disease. Science 148:1477–1479CrossRef

Titel: Enzephalitis
verfasst von: Uta Meyding-Lamadé
Eva Maria Craemer
Martin Stangel
Thorsten Lenhard
Burc Bassa
Christian Jacobi
Thomas Weber
Gabriele Arendt
Philipp Schwenkenbecher
Thomas Skripuletz
Inga Zerr
Stefan Schmiedel
Verlag: Springer Berlin Heidelberg
Buch: Neuroinfektiologie
Print ISBN: 978-3-662-61668-0

Electronic ISBN: 978-3-662-61669-7

Copyright-Jahr: 2021
DOI: https://doi.org/10.1007/978-3-662-61669-7_7

Springer Medizin

7. Enzephalitis

Zusammenfassung

Neu in den Fachgebieten Neurologie und Psychiatrie

Typ-2-Diabetes und Depression folgen oft aufeinander

Schützt Olivenöl vor dem Tod durch Demenz?

Darf man die Behandlung eines Neonazis ablehnen?

Chirurginnen und Chirurgen sind stark suizidgefährdet

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu in den Fachgebieten Neurologie und Psychiatrie

Typ-2-Diabetes und Depression folgen oft aufeinander

Schützt Olivenöl vor dem Tod durch Demenz?

Darf man die Behandlung eines Neonazis ablehnen?

Chirurginnen und Chirurgen sind stark suizidgefährdet